Preliminary screening for OSA in children who are awake, performed via an EEG, may help identify whether oxygen desaturation occurs at night.

the FDA approved prescription medicine for Obstructive Sleep Apnea. Research shows that it considerably improves the level of AHI in patients with OSA. This happens as it activates the two ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

ILI was associated with an improvement of obstructive sleep apnea, determined by a mean AHI decrease of 9.7 events per hour compared with that in the DSE patient group. Study participants with a ...

Obstructive sleep apnea (OSA) and metabolic syndrome (MetS) are increasingly recognized as interrelated conditions with significant implications for ...

A groundbreaking EEG study using topological data analysis uncovers key differences in brain connectivity in children with ...

The dual GLP-1 and GIP agonist reduced the apnoea-hypopnoea index (AHI) by up to 63% at 52 weeks, which Lilly said was equivalent to around 30 fewer breathing interruptions per hour. SURMOUNT-OSA ...

Moreover, the increased CO levels were normalized by treatment with CPAP in OSA patients ... of CO with hypoxia duration in terms of TST and AHI, the improvement in the oxidative condition ...